InvestorsHub Logo
Followers 56
Posts 8436
Boards Moderated 0
Alias Born 05/14/2015

Re: Schuller post# 112174

Monday, 08/15/2022 11:51:29 AM

Monday, August 15, 2022 11:51:29 AM

Post# of 118384
Well, that's incorrect about Lilly not breaching Regen's patents. All Lilly did was give Regen access to their molecular library.

What is conveniently left out is that Lilly had absolutely NO INTEREST in what Regen found. Molecules that interact with a receptor isn't evidence that any of those molecules will do anything to cure anything.

And that's WHY Lilly showed ZERO interest in anything Regen had! Lilly might have told Deadbeat Dave, "prove that what you have regarding regulating NR2f6 and then we'll talk" but we all know that will never happen as Deadbeat Dave has no money to actually move forward with testing the receptor.

How's that for a really hard and inconvenient fact along with there won't be any buy out unless it is micro pennies on the penny! And I even doubt that will happen.

LOL ROFL PIMPL!!!

FACTS are stubborn things